Maury Raycroft
Stock Analyst at Jefferies
(4.31)
# 1,300
Out of 4,371 analysts
235
Total ratings
42%
Success rate
10.4%
Average return
Main Sectors:
Stocks Rated by Maury Raycroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COAG Hemab Therapeutics Holdings | Initiated Coverage: Buy | $39 | $26.17 | +49.03% | 1 | May 26, 2026 | |
| TNGX Tango Therapeutics | Downgraded: Hold | $19 → $27 | $21.47 | +25.76% | 2 | May 14, 2026 | |
| CRBP Corbus Pharmaceuticals Holdings | Maintained: Buy | $53 → $33 | $7.38 | +347.15% | 7 | May 12, 2026 | |
| BCYC Bicycle Therapeutics | Maintained: Buy | $12 | $4.20 | +185.71% | 1 | Apr 30, 2026 | |
| CMPX Compass Therapeutics | Maintained: Buy | $8 → $9 | $2.10 | +328.57% | 4 | Apr 27, 2026 | |
| ERAS Erasca | Maintained: Buy | $6 → $21 | $13.18 | +59.33% | 2 | Apr 13, 2026 | |
| IDYA IDEAYA Biosciences | Maintained: Buy | $14 → $52 | $28.40 | +83.10% | 2 | Apr 5, 2026 | |
| KOD Kodiak Sciences | Rated: Buy | $39 → $56 | $33.87 | +65.34% | 4 | Mar 26, 2026 | |
| VALN Valneva SE | Maintained: Buy | $14 → $15 | $5.58 | +168.82% | 7 | Mar 23, 2026 | |
| DNTH Dianthus Therapeutics | Maintained: Buy | $66 → $98 | $84.97 | +15.33% | 4 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $1.67 | +1,576.65% | 2 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $26.95 | +41.00% | 10 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $20 | $4.58 | +336.68% | 5 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $10 → $21 | $15.67 | +34.01% | 16 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2 → $1.6 | $1.46 | +9.59% | 4 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $384 → $549 | $292.58 | +87.64% | 35 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $15 | $8.25 | +81.82% | 13 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $41 | $29.55 | +38.75% | 1 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 → $35 | $45.20 | -22.57% | 4 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 → $79 | $88.95 | -11.19% | 3 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $23 | $7.84 | +193.37% | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $3.5 | $1.40 | +150.00% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $5.55 | +44.14% | 3 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $9 | $3.14 | n/a | 2 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $15 | $6.85 | n/a | 2 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2 → $1.5 | $0.2162 | n/a | 8 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $0.3342 | n/a | 1 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $1.34 | n/a | 4 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $31 | $28.69 | n/a | 5 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $129 | $22.41 | n/a | 14 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $20 | $0.000001 | n/a | 5 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $26.91 | n/a | 1 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $1.27 | n/a | 1 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $6 → $26 | $31.27 | n/a | 5 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $75 | $72.55 | n/a | 7 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $172 → $159 | $52.08 | n/a | 6 | Sep 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $39 → $5 | $1.76 | n/a | 4 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 → $109 | $13.02 | n/a | 7 | Jun 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $25 | $9.63 | n/a | 11 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 → $86 | $17.17 | n/a | 2 | Jul 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 → $35 | $8.93 | n/a | 6 | Jun 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $6.04 | n/a | 2 | May 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $47 | $2.10 | n/a | 1 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $16 | $53.44 | n/a | 6 | Aug 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $5.67 | n/a | 2 | May 22, 2018 |
Hemab Therapeutics Holdings
May 26, 2026
Initiated Coverage: Buy
Price Target: $39
Current: $26.17
Upside: +49.03%
Tango Therapeutics
May 14, 2026
Downgraded: Hold
Price Target: $19 → $27
Current: $21.47
Upside: +25.76%
Corbus Pharmaceuticals Holdings
May 12, 2026
Maintained: Buy
Price Target: $53 → $33
Current: $7.38
Upside: +347.15%
Bicycle Therapeutics
Apr 30, 2026
Maintained: Buy
Price Target: $12
Current: $4.20
Upside: +185.71%
Compass Therapeutics
Apr 27, 2026
Maintained: Buy
Price Target: $8 → $9
Current: $2.10
Upside: +328.57%
Erasca
Apr 13, 2026
Maintained: Buy
Price Target: $6 → $21
Current: $13.18
Upside: +59.33%
IDEAYA Biosciences
Apr 5, 2026
Maintained: Buy
Price Target: $14 → $52
Current: $28.40
Upside: +83.10%
Kodiak Sciences
Mar 26, 2026
Rated: Buy
Price Target: $39 → $56
Current: $33.87
Upside: +65.34%
Valneva SE
Mar 23, 2026
Maintained: Buy
Price Target: $14 → $15
Current: $5.58
Upside: +168.82%
Dianthus Therapeutics
Mar 9, 2026
Maintained: Buy
Price Target: $66 → $98
Current: $84.97
Upside: +15.33%
Feb 25, 2026
Maintained: Buy
Price Target: $28
Current: $1.67
Upside: +1,576.65%
Jan 9, 2026
Reiterated: Buy
Price Target: $38
Current: $26.95
Upside: +41.00%
Dec 8, 2025
Maintained: Buy
Price Target: $15 → $20
Current: $4.58
Upside: +336.68%
Nov 7, 2025
Upgraded: Buy
Price Target: $10 → $21
Current: $15.67
Upside: +34.01%
Oct 31, 2025
Downgraded: Hold
Price Target: $2 → $1.6
Current: $1.46
Upside: +9.59%
Oct 30, 2025
Maintained: Buy
Price Target: $384 → $549
Current: $292.58
Upside: +87.64%
Oct 14, 2025
Maintained: Buy
Price Target: $14 → $15
Current: $8.25
Upside: +81.82%
Oct 9, 2025
Initiated Coverage: Buy
Price Target: $41
Current: $29.55
Upside: +38.75%
Sep 10, 2025
Reiterated: Buy
Price Target: $38 → $35
Current: $45.20
Upside: -22.57%
Aug 15, 2025
Maintained: Buy
Price Target: $33 → $79
Current: $88.95
Upside: -11.19%
Aug 13, 2025
Maintained: Buy
Price Target: $40 → $23
Current: $7.84
Upside: +193.37%
Jun 24, 2025
Initiated Coverage: Hold
Price Target: $3.5
Current: $1.40
Upside: +150.00%
Jun 11, 2025
Maintained: Buy
Price Target: $8
Current: $5.55
Upside: +44.14%
May 19, 2025
Maintained: Buy
Price Target: $15 → $9
Current: $3.14
Upside: n/a
May 16, 2025
Maintained: Buy
Price Target: $7 → $15
Current: $6.85
Upside: n/a
May 13, 2025
Maintained: Buy
Price Target: $2 → $1.5
Current: $0.2162
Upside: n/a
Dec 6, 2024
Initiated Coverage: Buy
Price Target: $7
Current: $0.3342
Upside: n/a
Nov 13, 2024
Maintained: Buy
Price Target: $21
Current: $1.34
Upside: n/a
Oct 17, 2024
Maintained: Buy
Price Target: $25 → $31
Current: $28.69
Upside: n/a
Oct 4, 2024
Rated: Buy
Price Target: $129
Current: $22.41
Upside: n/a
Apr 4, 2024
Maintained: Buy
Price Target: $10 → $20
Current: $0.000001
Upside: n/a
Mar 13, 2024
Initiated Coverage: Buy
Price Target: $6
Current: $26.91
Upside: n/a
Feb 8, 2024
Initiated Coverage: Buy
Price Target: $15
Current: $1.27
Upside: n/a
Nov 9, 2023
Upgraded: Buy
Price Target: $6 → $26
Current: $31.27
Upside: n/a
Nov 29, 2022
Maintained: Buy
Price Target: $75
Current: $72.55
Upside: n/a
Sep 29, 2022
Reiterated: Buy
Price Target: $172 → $159
Current: $52.08
Upside: n/a
Dec 1, 2021
Downgraded: Hold
Price Target: $39 → $5
Current: $1.76
Upside: n/a
Jun 22, 2021
Maintained: Buy
Price Target: $37 → $109
Current: $13.02
Upside: n/a
Dec 21, 2020
Maintained: Hold
Price Target: $14 → $25
Current: $9.63
Upside: n/a
Jul 29, 2020
Maintained: Buy
Price Target: $34 → $86
Current: $17.17
Upside: n/a
Jun 23, 2020
Maintained: Buy
Price Target: $34 → $35
Current: $8.93
Upside: n/a
May 18, 2020
Maintained: Buy
Price Target: $25
Current: $6.04
Upside: n/a
Feb 24, 2020
Initiated Coverage: Buy
Price Target: $47
Current: $2.10
Upside: n/a
Aug 10, 2018
Reiterated: Buy
Price Target: $9 → $16
Current: $53.44
Upside: n/a
May 22, 2018
Reiterated: Buy
Price Target: $28
Current: $5.67
Upside: n/a